Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

35 results about "Hypertension risk" patented technology

Monitor for gestational hypertension risk on basis of physiology, biochemistry and blood dynamics information

The invention discloses a monitor for gestational hypertension risk on the basis of physiology, biochemistry and blood dynamics information, relating to the technical field of medical equipment. The monitor is characterized by being a device which can input physiology, biochemistry and blood dynamics information of gestational women in an array mode and expresses the gestational hypertension risk by numerical values, bar codes and colors. The device comprises a gestational woman physiology and biochemistry information induction module, a gestational woman blood dynamics information induction module, a logic switch array formation module for the physiology, biochemistry and blood dynamics information of the gestational hypertension risk, a bar code generation module for the gestational hypertension risk, a logic switch value regression calculation module for the gestational hypertension risk, a color generation module for the gestational hypertension risk and a display output module for the gestational hypertension risk. The monitor can automatically induce the physiology, biochemistry and blood dynamics information of the gestational women, and effectively improves the automation degree and the informatization degree for monitoring the gestational hypertension.
Owner:BEIJING YES MEDICAL DEVICES

INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF

The present invention relates to methods, kits and compositions to treat hypertension and other cardiovascular diseases in a subject, in particular, a method of treating or preventing a cardiovascular disease in a subject comprising administering to a subject at least one anti-miR agent to miRNA-425. In some embodiments, an anti-miR agent is a small molecule or an oligonucleotide complementary to at least part of the miR-425 of SEQ ID NO: 1, or an anti-miR complementary to at least part of the miRNA seed sequence AUGACA (SEQ ID NO: 2). Another aspect of the present invention relates to methods, kits and compositions to treat low blood pressure in a subject comprising administering a composition comprising a miR-425 agent to decrease ANP levels in the subject. Other aspects of the present invention relates to assays, methods and systems to identify a subject at risk of hypertension, or identifying a subject suitable to administration of an anti-miR-425 agent for treatment of hypertension, the assay comprising assessing if a subject is homozygous or heterozygous for the major (A) allele of rs5068 SNP, and/or assaying for levels of miR-425 and/or assaying for levels of NT-proANP and/or levels of ANP in the plasma of a subject.
Owner:THE GENERAL HOSPITAL CORP

Hypertension risk prediction method, device, and equipment and medium

The invention relates to the field of medical science and technology, and provides a hypertension risk prediction method, device and equipment and a medium. The method comprises the following steps: obtaining the individual information and a fundus image of a to-be-detected target; respectively inputting the fundus image into a preset arteriovenous segmentation model, an optic disk segmentation model and a lesion recognition model, and respectively extracting arteriovenous blood vessels, optic disk regions and fundus lesion features in the fundus image; quantifying the diameters of arteriovenous blood vessels in the optic disc area to obtain blood vessel diameter quantized values corresponding to the arteriovenous blood vessels respectively; using a machine learning regression method to construct a risk prediction model for predicting the hypertension of the target to be detected based on the blood vessel diameter quantized value, the fundus lesion features and the individual information; and inputting the fundus image corresponding to the to-be-detected target into the risk prediction model for detection to obtain a hypertension prediction result of the to-be-detected target. The risk prediction model is trained by adopting a plurality of variable factors, so that the accuracy of hypertension risk prediction is greatly improved.
Owner:PING AN TECH (SHENZHEN) CO LTD

Gestation hypertension risk dynamic evaluation method based on the change of the physical and chemical information of pregnancy

The invention relates to the field of obstetrics, in particular to a gestation hypertension risk dynamic evaluation method based on the change of the physical and chemical information of pregnancy. The invention is characterized in that different evaluation criteria can be selected according to the pregnancy cycle, automatic identification is carried out on the physical and chemical information, and the change tendency of the information parameters in the gestation period is monitored, and whether the information parameters are abnormal or not is evaluated according to the comparison between the physical and chemical information and the experimental values. Aiming at different pregnant women or the same pregnant women at different gestational weeks, the doctor can use the historical medical information, the current physical and chemical information and the diagnosis and treatment experience, the risk weights of the physical and chemical parameters are adjusted, and the risk that the pregnant women suffer from hypertension and related complications is evaluated, so that the medical process has good flexibility. According to the evaluation method, the pre-pregnancy medical history iscombined with the post-pregnancy information, the dynamic monitoring is combined with the static estimation, and the current detection is combined with the trend estimation, the single detection andthe overall evaluation are combined, so that the monitoring can have real-time ability, prediction performance and pertinence, and the intervention can be carried out on the pregnant woman in advance,and the harm of the mother and the baby can be reduced.
Owner:BEIJING UNIV OF TECH

Preparation method for kidney-tonifying healthcare medicinal liquor

The invention provides a preparation method for a kidney-tonifying healthcare medicinal liquor. According to the theory of kidney being congenital origin in the traditional Chinese medicine, the medicinal liquor prepared according to the invention mainly has the effect of reinforcing kidney to strengthen yang, adopts high-quality medicinal materials, is processed on the basis of reservation of substance nutritional ingredients and healthcare function, has the functions of enhancing physical power and promoting sexual function, is capable of improving vascular elasticity so as to reduce high blood pressure risk, is suitable for people suffering from the symptoms, such as, kidney deficiency, impotence, premature ejaculation, lumbago, weakness, prematurely senile, and the like, is also suitable for people suffering from cardiovascular disease and is a functional Yang-strengthening healthcare medicinal liquor.
Owner:FOSHAN UNIVERSITY

Medicinal liquor for invigorating kidney and strengthening Yang and preparation method thereof

The invention discloses a medicinal liquor for invigorating the kidney and strengthening Yang and a preparation method thereof. The medicinal liquor comprises raw herbal materials and wine, wherein the raw herbal materials comprise, by weight, 8-15 parts of hippocampi, 10-20 parts of cornu cervi pantotrichum, 7-15 parts of ganoderma, 3-8 parts of epimedium herb, 5-10 parts of radix codonopsis, 5-12 parts of herba cistanche, 2-10 parts of American ginseng, 5-10 parts of crocus sativus, 5-20 parts of fructus lycii, 5-20 parts of red jujubes, 5-20 parts of mulberry fruits and 100 parts of Baijiu.The medicinal liquor prepared by using the preparation method is mainly used for invigorating the kidney and strengthening Yang, the high-quality raw herbal materials are selected, on the basis of reserving nutrient ingredients of the materials and the health-care function, the raw herbal materials are processed and prepared, the medicinal liquor has the functions of enhancing the physical strength, improving the sexual function, improving the vascular elasticity and thus reducing the hypertension risk, the medicinal liquor is suitable for deficiency of the kidney, impotence, prospermia, lumbagos, weakness, prematurely senile and other disease symptoms, and the medicinal liquor has a certain treatment effect on diabetes, cerebral infarction and cerebral thrombosis.
Owner:韩体亮

Intelligent pregnancy-induced hypertension monitoring device

The invention provides an intelligent pregnancy-induced hypertension monitoring device, which comprises an information input module, a data acquisition module, a vital sign standard value estimation module, a data storage module, a pregnancy-induced hypertension risk prediction module, an alarm module and a result display module, and is characterized in that the vital sign standard value estimation module comprises an estimation module and a sample library. The vital sign standard value estimation module is used for determining a vital sign standard value of the monitored person by carrying out similarity matching with samples in a sample library according to the basic information of the monitored person and a medically specified vital sign normal value; taking the vital sign standard value as a control limit, and predicting and pre-warning the pregnancy-induced hypertension risk of the monitored person by collecting the vital sign parameters of the monitored person in real time. According to the invention, monitoring and early warning can be carried out in a targeted manner according to individual states of different monitors, high efficiency and high accuracy are achieved, and the problem of monitoring errors caused by individual differences and time differences is solved.
Owner:刘艳妮

Hypertension risk early warning scheme determination method based on generalized orthogonal fuzzy group decision

The invention discloses a generalized orthogonal fuzzy group decision-making-based hypertension risk early warning scheme determination method, which comprises a group decision-making method integrating an interval value generalized orthogonal fuzzy distance, a Yager operator, a CRITIC-WASPAS decision-making method, a decision maker weight and a score function, and a researched group decision-making algorithm is used for hypertension risk management. A case implementation result of the method is consistent with an opinion given by a decision maker, and the group decision method provided by the invention is verified to be effective.
Owner:JIANGXI UNIVERSITY OF FINANCE AND ECONOMICS

Glove for detecting multiple physiological parameters and hypertension disease risk detection system

The invention provides a glove for detecting multiple physiological parameters and a hypertension disease risk detection system. The glove comprises a main control module, an electrocardiosignal acquisition assembly and a comprehensive signal acquisition assembly, the electrocardiosignal acquisition assembly comprises a plurality of electrodes arranged on the palm side of the outer surface of the glove body and an electrocardiosignal acquisition module connected with each electrode, and the electrocardiosignal acquisition assembly is used for acquiring electrocardiosignals; the comprehensive signal acquisition component is arranged at any fingertip position on the inner surface of the glove body and is used for acquiring a pulse wave signal by adopting a transmission-type blood oxygen acquisition mode; acquiring the oxyhemoglobin saturation by adopting a spectrophotometric measurement method and a transmission-type blood oxygen acquisition mode; and the main control module is used for sending the acquired electrocardiosignal, oxyhemoglobin saturation and pulse wave signal to external equipment to determine the risk probability of hypertension of the user. According to the invention, multiple physiological parameters of a human body can be monitored in real time so as to predict the hypertension risk.
Owner:SECOND MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

An intelligent pregnancy-induced hypertension monitoring device

The invention provides an intelligent pregnancy-induced hypertension monitoring device, which comprises an information input module, a data acquisition module, a vital sign standard value estimation module, a data storage module, a pregnancy-induced hypertension risk prediction module, an alarm module and a result display module, and is characterized in that the vital sign standard value estimation module comprises an estimation module and a sample library. The vital sign standard value estimation module is used for determining a vital sign standard value of the monitored person by carrying out similarity matching with samples in a sample library according to the basic information of the monitored person and a medically specified vital sign normal value; taking the vital sign standard value as a control limit, and predicting and pre-warning the pregnancy-induced hypertension risk of the monitored person by collecting the vital sign parameters of the monitored person in real time. According to the invention, monitoring and early warning can be carried out in a targeted manner according to individual states of different monitors, high efficiency and high accuracy are achieved, and the problem of monitoring errors caused by individual differences and time differences is solved.
Owner:刘艳妮
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products